Losartan and Simvastatin Inhibit Platelet Activation in Hypertensive Patients

By Nomura Shosaku   Shouzu Akira   Omoto Seitarou   Nishikawa Mitsushige   Fukuhara Shirou   Iwasaka Toshiji  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 3, 2004-12 ,pp. : 177-185

Springer Publishing Company

Access to resources Recommend Favorite

Flow cytometric analysis of platelet activation in hypertensive patients. Effect of doxazosin

By Labios M.   Martinez M.   Gabriel F.   Gomez-Biedma S.   Guiral V.   Vivo M.   Aznar J.  

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 203-208

Elsevier

Access to resources Recommend Favorite

Antibodies to Platelet Factor 4/Heparin are Associated with Elevated Endothelial Cell Activation Markers in Patients with Acute Coronary Ischemic Syndromes

By Mascelli Mary   Deliargyris Efthymios   Damaraju Lakshmi   Barnathan Elliot   Califf Robert   Simoons Maarten   Sane David  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 3, 2004-12 ,pp. : 171-175

Springer Publishing Company

Access to resources Recommend Favorite

Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamole

By Nomura Shosaku   Iwasaka Toshiji   Liu Yongge   Inami Norihito  

Platelets, Vol. 15, Iss. 3, 2004-05 ,pp. : 167-172

Informa Healthcare

Access to resources Recommend Favorite

The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy

By Nomura Shosaku   Fujita Shinya   Ozasa Ryotaro   Nakanishi Takahisa   Miyaji Michihiko   Mori Shinichiro   Ito Tomoki   Ishii Kazuyoshi  

Platelets, Vol. 22, Iss. 5, 2011-08 ,pp. : 396-397

Informa Healthcare

Access to resources Recommend Favorite